Private Advisor Group, LLC Celldex Therapeutics, Inc. Transaction History
Private Advisor Group, LLC
- $17.4 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$102 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$94.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$78.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$75.6 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$71.7 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $942M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...